Abstract |
Sleep disturbance is common in patients with Alzheimer's disease (AD), and orexin A is a pivotal neurotransmitter for bidirectionally regulating the amyloid-β (Aβ) deposition of AD brain and poor sleep. In the present study, we examined the characteristic of sleep-wake architecture in APPswe/PSldE9 (APP/PS1) and Aβ-treated mice using electroencephalogram (EEG) and electromyographic (EMG) analysis. We compared the expression of orexin A, distribution, and morphology of the corresponding orexin A-positive neurons using innovative methods including three-dimensional reconstruction and brain tissue clearing between wild type (WT) and APP/PS1 mice. Results from our study demonstrated that increased wakefulness and reduced NREM sleep were seen in APP/PS1 and Aβ treated mice, while the expression of orexin A was significantly upregulated. Higher density and distribution of orexin A-positive neurons were seen in APP/PS1 mice, with a location of 1.06 mm-2.30 mm away from the anterior fontanelle compared to 1.34 mm-2.18 mm away from the anterior fontanelle in WT mice. These results suggested that the population and distribution of orexin A may play an important role in the progression of AD.
|
Authors | Peng Zhao, Yaqian You, Zhe Wang, Yanjun Zhou, Gaoshang Chai, Gen Yan, Zhewu Jin, Qing Wang, Hongxu Sun |
Journal | Brain structure & function
(Brain Struct Funct)
Vol. 227
Issue 3
Pg. 1051-1065
(Apr 2022)
ISSN: 1863-2661 [Electronic] Germany |
PMID | 35066609
(Publication Type: Journal Article)
|
Copyright | © 2022. The Author(s). |
Chemical References |
- Amyloid beta-Peptides
- Amyloid beta-Protein Precursor
- Hcrt protein, mouse
- Orexins
- Presenilin-1
|
Topics |
- Alzheimer Disease
(metabolism)
- Amyloid beta-Peptides
(metabolism)
- Amyloid beta-Protein Precursor
(genetics, metabolism)
- Animals
- Brain
(metabolism)
- Disease Models, Animal
- Humans
- Mice
- Mice, Transgenic
- Orexins
(metabolism)
- Presenilin-1
(genetics, metabolism)
- Sleep
|